Companies: 10,795·Total market cap: $144.5T

Abcam plc

Abcam plc

ABCMNASDAQHealthcare

$23.99

+$0.01(+0.04%)

Market Cap$5.5B

P/E Ratio—

52W High$25.32

52W Low$12.48

Avg Volume5.1M

Open$23.99

Beta0.86

Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Abcam plc (ABCM) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ABCM · as of Jun 9, 2026

Key Statistics

EPS (TTM)$0.06Earnings history

PE Ratio (TTM)380.8×PE Ratio deep dive

Revenue (TTM)$731.8MFull revenue history

Dividend Yield1.13%Dividend history

Shares Outstanding228.7MShares outstanding history

Next EarningsTBAEarnings history

Explore Abcam plc Data

Market Cap$5.5B

Analyst Forecast$— · Hold

Revenue$361.7M-23.36%

EarningsEPS $-0.04-147.57%

PE Ratio380.8×

Financial Snapshot

Full Financials

FY 2022Revenue$361.7M▼ 23.36% YoY

202120212022

FY 2022Net Income-$8.5M▼ 148.47% YoY

202120212022

FY 2022EPS$-0.04▼ 147.57% YoY

202120212022

TTM:Revenue: $731.8MNet Income: $14.7MEPS: $0.06View income statement →

Analyst Ratings & Price Target

Hold5 analysts

Strong Buy

0

Buy

1

Hold

4

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$23.99Current

$—Avg Target

$—High

Total: 5 · Buy rate: 20.0%

Competitors & Peers

#TickerCompanyPriceChangeMkt Cap

$23.99+0.04%$5.5B #2

Alpine Immune Sciences, Inc.

$64.97+0.02%$4.5B #3

CymaBay Therapeutics, Inc.

$32.48+0.03%$3.7B #4

IVERIC bio, Inc.

$39.95+0.38%$5.5B #5

LHC Group, Inc.

$169.81+0.00%$5.3B #6

Mirati Therapeutics, Inc.

$58.70-0.17%$4.1B

Stock Performance

1D+0.00%

1W+0.00%

1M+0.04%

3M+5.45%

YTD+0.00%

1Y+41.12%

5Y+66.29%

About Abcam plc

CEOAlan Thomas Hirzel BS,

IPO DateOct 22, 2020

Employees1,760

CountryGB

Websiteabcam.com

Abcam plc operates as a prominent life science enterprise, dedicated to the innovation, creation, and supply of crucial reagents and instruments. These fundamental resources are instrumental in suppor…

Biotechnology HealthcareNASDAQADRGB

About Stock Overview & Key Data

Abcam plc (ABCM) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 22, 2020. As of the latest trading session, ABCM stock price is $23.99, with a market capitalization of $5.5B. The stock has returned +41.12% over the past 12 months and +0.00% year-to-date.

According to 5 Wall Street analysts, the consensus rating for Abcam plc stock is Hold, with an average 12-month price target of $—. In fiscal year 2022, Abcam plc reported revenue of $361.7M and net income of -$8.5M. For detailed data — including Abcam plc revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Abcam plc (ABCM) stock price is $23.99. The stock is traded on NASDAQ under the ticker symbol ABCM. The 52-week range is $12.48 – $25.32.

ABCM stock priceABCM quote todaylive ticker

Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice